Vikram Verghese - 07 Aug 2025 Form 3 Insider Report for Heartflow, Inc. (HTFL)

Role
Chief Financial Officer
Signature
/s/ Angela Ahmad, Attorney-in-Fact for Vikram Verghese
Issuer symbol
HTFL
Transactions as of
07 Aug 2025
Transactions value $
$0
Form type
3
Filing time
07 Aug 2025, 21:15:18
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Verghese Vikram Chief Financial Officer C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW /s/ Angela Ahmad, Attorney-in-Fact for Vikram Verghese 07 Aug 2025 0002079946

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HTFL Common Stock 115K 07 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HTFL Stock Option 07 Aug 2025 Common Stock 7.85K $8.33 Direct F1, F2
holding HTFL Stock Option 07 Aug 2025 Common Stock 77.4K $2.22 Direct F1, F3
holding HTFL Stock Option 07 Aug 2025 Common Stock 112K $2.22 Direct F1, F4
holding HTFL Stock Option 07 Aug 2025 Common Stock 198K $9.58 Direct F1, F5
holding HTFL Convertible Promissory Note 07 Aug 2025 Common Stock $145K Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares of common stock and exercise price, as applicable, give effect to the 1-for-2.92 reverse stock split of Heartflow, Inc.'s ("Heartflow") common stock, which became effective on July 31, 2025.
F2 The option is vested and exercisable as to 4,993 shares, and the remaining shares will vest and become exercisable in monthly installments until November 8, 2025, subject to continued service through the applicable vesting date.
F3 The option is vested and exercisable as to 19,972 shares, and the remaining shares will vest and become exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
F4 The option is vested and exercisable as to 22,981 shares, and the remaining shares will vest and become exercisable in monthly installments until October 30, 2027, subject to continued service through the applicable vesting date.
F5 The option is vested and exercisable as to 28,811 shares, and the remaining shares will vest and become exercisable in monthly installments until December 16, 2028, subject to continued service through the applicable vesting date.
F6 Represents the outstanding principal amount of a convertible promissory note held by Mr. Verghese, which will automatically convert upon consummation of Heartflow's initial public offering into shares of common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. These shares of common stock issuable upon conversion of the convertible promissory note have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney.